 Regeneron Pharmaceuticals Inc. REGN, -2.56 said Thursday its third-quarter net income fell 19 to 1.32 billion or 11.66 a share, from 1.63 billion or 14.33 a share, in the year-ago period. Adjusted net income fell to 11.14 a share from 15.37 a share. 